Application‑based segmentation partitions the market into PCR, ELISA, cell‑based assays, and other specialized workflows. PCR laboratories generate the largest demand, as precise thermal sealing is essential for preventing sample cross‑contamination during thermocycling; this segment drives approximately 40 % of total market volume. ELISA platforms, which require consistent plate sealing to maintain reagent stability during incubation, represent a 30 % share, reflecting the assay’s widespread use in diagnostics and drug discovery. Cell‑based assays, increasingly employed for high‑content screening, depend on robust seals to sustain humidified environments, contributing 20 % of revenue. The residual 10 % comprises niche applications such as enzymatic assays and multiplexed formats. Understanding this market taxonomy enables stakeholders to align product development with the specific performance criteria of each assay type, thereby optimizing portfolio allocation across the diverse user base.